Paclitaxel Cationic Liposome (Hepatic Arterial Infusion) in Combination With Systemic Therapy as First-Line Treatment in Colorectal Liver Metastases

Clinical trial NCT07117435 · RECRUITING

Trial details

NCT number: NCT07117435
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Liver Metastases First-line Treatment

Start date: 2025-05-13
Primary completion: 2025-12-30
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.